Safety Profile of Ceftazidime–Avibactam: Pooled Data from the Adult Phase II and Phase III Clinical Trial Programme

INTRODUCTION: Ceftazidime–avibactam combines the established anti-pseudomonal cephalosporin, ceftazidime, with the novel non-β-lactam β-lactamase inhibitor, avibactam. OBJECTIVES: The aim of this study was to evaluate the safety of ceftazidime–avibactam in adults using pooled data from two phase II...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Karen, Newell, Paul, Chow, Joseph W., Broadhurst, Helen, Wilson, David, Yates, Katrina, Wardman, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395917/
https://www.ncbi.nlm.nih.gov/pubmed/32602065
http://dx.doi.org/10.1007/s40264-020-00934-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395917/
https://www.ncbi.nlm.nih.gov/pubmed/32602065
http://dx.doi.org/10.1007/s40264-020-00934-3

Ejemplares similares